AstraZeneca resumes COVID-19 trial in Japan but still keeps its US trial on pause - Business Insider

United States News News

AstraZeneca resumes COVID-19 trial in Japan but still keeps its US trial on pause - Business Insider
United States Latest News,United States Headlines
  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 40 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 19%
  • Publisher: 51%

AstraZeneca resumes COVID-19 trial in Japan but still keeps its US trial on pause

and Oxford University's COVID-19 vaccine have resumed in Japan, almost one month after the company halted large-scale global tests after a participant fell ill.

"The Phase I/II clinical trial for the COVID-19 vaccine AZD1222 has resumed in Japan after discussion with the Japanese Pharmaceuticals and Medical Devices Agency ," AstraZeneca said in aAstraZeneca's phase three coronavirus vaccine trial, which is said to be one of the most advanced right now, was put on hold on September 6 after a participant in the UK reportedly fell ill with a rare spinal inflammatory disorder called transverse myelitis.

The US has bagged almost a third of the first one billion doses planned for AstraZeneca's experimental COVID-19 vaccine by pledging up to $1.2 billion, as countries scramble for effective treatment for the disease.of AstraZeneca's vaccine, meaning it could be the first vaccine to gain approval in the region.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

BusinessInsider /  🏆 729. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

TikTok employees describe life inside the company as its future hangs in the balance - Business InsiderTikTok employees describe life inside the company as its future hangs in the balance - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Read more »

AstraZeneca's Japanese COVID-19 vaccine trial back up, U.S. still pausedAstraZeneca's Japanese COVID-19 vaccine trial back up, U.S. still pausedClinical trials of AstraZeneca and Oxford University's experimental COVID-19 vaccine have resumed in Japan, almost a month after being put on hold due to an illness of a British volunteer, while discussions with U.S. authorities continue.
Read more »

We Need One Million More Volunteers for the COVID-19 Vaccine TrialsWe Need One Million More Volunteers for the COVID-19 Vaccine TrialsIn order to have effective vaccine trials, America needs another one million volunteers to sign up, especially from diverse backgrounds.
Read more »

Amid COVID-19 outbreak, San Diego State to resume limited in-person classesAmid COVID-19 outbreak, San Diego State to resume limited in-person classesThe announcement comes at a time when more than 1,050 students at SDSU have tested positive for COVID-19.
Read more »

Johnson, who nearly died from COVID-19, wishes Trump 'speedy recovery' - Business InsiderJohnson, who nearly died from COVID-19, wishes Trump 'speedy recovery' - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Read more »

Donald Trump: The VIPs who belittled COVID-19 threat then got infected - Business InsiderDonald Trump: The VIPs who belittled COVID-19 threat then got infected - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Read more »



Render Time: 2025-02-26 11:18:56